Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Anavex Lf SC (NQ: AVXL )

11.66 +0.83 (+7.66%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 5, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 928,157
Open 10.61
Bid (Size) 11.50 (2)
Ask (Size) 11.60 (1)
Prev. Close 10.83
Today's Range 10.40 - 11.66
52wk Range 7.130 - 23.73
Shares Outstanding 77,408,976
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Why Qudian Shares Jumped Over 40%; Here Are 73 Biggest Movers From Yesterday
Gainers AMTD Digital Inc. (NYSE: HKD) climbed 71.5% to close at $27.80 on Monday after gaining 108% on Friday. The company priced its IPO at $7 per share. 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
  This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga

Performance

YTD
-34.09%
-34.09%
1 Month
-8.76%
-8.76%
3 Month
+53.62%
+53.62%
6 Month
+6.00%
+6.00%
1 Year
-38.79%
-38.79%

More News

Read More
Recap: Anavex Life Sciences Q1 Earnings
Via Benzinga
Earnings Scheduled For February 9, 2022
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 23, 2022
Via Benzinga
Anavex: Alzheimer's To Parkinson's Dementia
Via Talk Markets
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Anavex Life Sciences Corp. Investors With Losses to Inquire About Securities Class Action Investigation – AVXL
From The Rosen Law Firm, P.A.
Via Business Wire
Anavex Life Sciences Corp. (NASDAQ:AVXL) Investor Alert: Investigation over Potential Wrongdoing
Via SBWire
Anavex Life Sciences Highlights Biomarker Data From Parkinson's Disease Dementia At International Conference
Via Benzinga
NASDAQ:AVXL Shareholder Notice: Investigation over Potential Securities Laws Violations by Anavex Life Sciences Corp.
Via SBWire
The Daily Biotech Pulse: Bristol-Myers Squibb Announces $5B Accelerated Buyback, Qiagen Reaps COVID Testing Windfall, WORLDSymposium Presentations Kick In
Via Benzinga
Ongoing Investigation Reminder: The Schall Law Firm Encourages Investors in Anavex Life Sciences Corp. with Losses of $100,000 to Contact the Firm
Via NewMediaWire
Investigation Notice: The Schall Law Firm Encourages Investors in Anavex Life Sciences Corp. with Losses of $100,000 to Contact the Firm
Via NewMediaWire
ANAVEX ALERT: Bragar Eagel & Squire, P.C. is Investigating Anavex Life Sciences Corp. on Behalf of Anavex Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Anavex Life Sciences Corp. (AVXL) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Anavex Life Sciences Corp. (AVXL) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Anavex Life Sciences Corp. (AVXL) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Anavex Life Sciences Corp. with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
23 Stocks Moving in Wednesday's Pre-Market Session
Via Benzinga
Mid-Afternoon Market Update: Dow Rises 50 Points; DLH Holdings Shares Drop
Via Benzinga
52 Biggest Movers From Yesterday
Via Benzinga
Anavex Life Sciences Crashes As Last-Minute Testing Edits Cloud Drug's Impact
Via Investor's Business Daily
34 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Mid-Day Market Update: Pitney Bowes Drops After Q4 Earnings; Biofrontera Shares Climb
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.